The Hidden Bottlenecks in Early-Phase Clinical Research
Early-phase clinical research is where innovation meets uncertainty. It’s the stage where promising molecules transition from laboratory breakthroughs to first-in-human trials. But behind every successful Phase I or Phase II study lies a complex web of logistics, regulatory requirements, and operational coordination.
For many sponsors and research sites, the...